Hims & Hers: Deborah M. Autor proposes $442K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. (HIMS) officer and director Deborah M. Autor reported a proposed sale of 23,828 Class A shares, with an approximate sale date of November 17, 2026 and an aggregate market value of $441,532.84. She acquired 23,828 shares through restricted stock vesting from the issuer on November 15, 2026. The notice lists May 20, 2026 as the plan adoption or instruction date under Rule 10b5-1. During the prior three months, she sold 16,773 Class A shares on August 18, 2026, for gross proceeds of $467,128.05.
Key Figures
Key Terms
Restricted Stock Vesting technical
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.